Back
Science

Scientists Discover Key Regulator of Muscle Regeneration, Potentially Aiding Muscular Dystrophy Treatment

View source

Breakthrough in Muscle Regeneration: Researchers Identify Key Molecular Regulator

Researchers have identified a molecular mechanism that regulates skeletal muscle regeneration and repair. This significant discovery may lead to improved treatments for conditions such as muscular dystrophy and severe injuries.

Muscle cells, known as myocytes, fuse to each other to repair damaged muscle tissue. However, the precise molecular pathways governing this essential cell-to-cell fusion have been poorly understood until now. Daniel Berry, the Andre Bensadoun, Ph.D. '60 Associate Professor in the College of Human Ecology, highlighted the previous incomplete understanding of muscle regeneration post-injury or during aging.

Unveiling PDGFRb's Pivotal Role

A team led by Professor Berry identified platelet-derived growth factor receptor beta (PDGFRb), a receptor protein found in cell membranes, as a key modulator of myocyte function in adult muscle cells. The groundbreaking findings were published on February 16 in the Journal of Clinical Investigation.

The team initially uncovered PDGFRb's effects on muscle tissue serendipitously. They were investigating an inhibitor related to the cancer drug imatinib for its impact on fat tissue. Observations of altered muscle function in these studies prompted direct testing of PDGFRb's role in muscle through muscle-specific deletion experiments.

Dual Impact on Muscle Repair and Therapeutic Promise

Through both in vitro and in vivo experiments, genetic deletion of PDGFRb was found to significantly enhance muscle regeneration and increase myofiber size. Conversely, activating PDGFRb was observed to impair muscle repair, indicating a delicate balance in its regulatory function.

Further studies reinforced these findings, indicating that treating muscle cells with a PDGFRb-inhibiting drug improved muscle development. This suggests PDGFRb functions as a critical checkpoint in muscle regeneration, offering a compelling potential target for therapies aimed at improving functional muscle repair.

Daniel Berry noted, "This represents a newly recognized function for PDGFRb, traditionally viewed as a driver of cell growth and survival rather than a determinant of cell fusion."

Future Horizons and Collaboration

The research involved a collaborative effort with Anna Thalacker-Mercer, Ben Cosgrove, and Jamie Blum.

Ongoing research by Berry's team includes studying muscle development during the embryonic stage to understand its influence on muscle formation throughout an animal's lifetime. The ultimate goal of this work is to design strategies for muscle preservation during aging, disease, or rapid weight loss, enhancing overall muscle health and function.